Global Preimplantation Genetic Diagnostics (PGD) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Preimplantation genetic diagnosis (PGD) is a procedure used prior to implantation to help identify genetic defects within embryos. This serves to prevent certain geneticdiseases or disorders from being passed on to the child.
LPI (LP Information)' newest research report, the “Preimplantation Genetic Diagnostics (PGD) Industry Forecast” looks at past sales and reviews total world Preimplantation Genetic Diagnostics (PGD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Preimplantation Genetic Diagnostics (PGD) sales for 2023 through 2029. With Preimplantation Genetic Diagnostics (PGD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preimplantation Genetic Diagnostics (PGD) industry.
This Insight Report provides a comprehensive analysis of the global Preimplantation Genetic Diagnostics (PGD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preimplantation Genetic Diagnostics (PGD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preimplantation Genetic Diagnostics (PGD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preimplantation Genetic Diagnostics (PGD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preimplantation Genetic Diagnostics (PGD).
The global Preimplantation Genetic Diagnostics (PGD) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preimplantation Genetic Diagnostics (PGD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preimplantation Genetic Diagnostics (PGD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preimplantation Genetic Diagnostics (PGD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preimplantation Genetic Diagnostics (PGD) players cover Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Cooper Surgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Diagnostics (PGD) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Preimplantation genetic diagnosis (PGD) is a procedure used prior to implantation to help identify genetic defects within embryos. This serves to prevent certain geneticdiseases or disorders from being passed on to the child.
LPI (LP Information)' newest research report, the “Preimplantation Genetic Diagnostics (PGD) Industry Forecast” looks at past sales and reviews total world Preimplantation Genetic Diagnostics (PGD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Preimplantation Genetic Diagnostics (PGD) sales for 2023 through 2029. With Preimplantation Genetic Diagnostics (PGD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preimplantation Genetic Diagnostics (PGD) industry.
This Insight Report provides a comprehensive analysis of the global Preimplantation Genetic Diagnostics (PGD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preimplantation Genetic Diagnostics (PGD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preimplantation Genetic Diagnostics (PGD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preimplantation Genetic Diagnostics (PGD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preimplantation Genetic Diagnostics (PGD).
The global Preimplantation Genetic Diagnostics (PGD) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preimplantation Genetic Diagnostics (PGD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preimplantation Genetic Diagnostics (PGD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preimplantation Genetic Diagnostics (PGD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preimplantation Genetic Diagnostics (PGD) players cover Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Cooper Surgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Diagnostics (PGD) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Preimplantation Genetic Screening
- Preimplantation Genetic Diagnosis
- Fertility Clinics
- Academic Medical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Cooper Surgical
- ABBott Laboratories
- Natera, Inc.
- Rubicon Genomics
- Oxford Gene Technology
- Yikon Genomics
- Scigene
- Beijing Genomics Institute (BGI)
- Genea Limited
- Hamilton Thorne
- FUJIFILM Irvine Scientific
- Nidacon International
- Vitrolife AB
- Merck
- INVO Bioscience
- IVFtech
- Gonagen Medikal
- Cook Medical
- CellCura
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2029
2.1.2 Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Preimplantation Genetic Diagnostics (PGD) Segment by Type
2.2.1 Preimplantation Genetic Screening
2.2.2 Preimplantation Genetic Diagnosis
2.3 Preimplantation Genetic Diagnostics (PGD) Market Size by Type
2.3.1 Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
2.4 Preimplantation Genetic Diagnostics (PGD) Segment by Application
2.4.1 Fertility Clinics
2.4.2 Academic Medical Centers
2.4.3 Others
2.5 Preimplantation Genetic Diagnostics (PGD) Market Size by Application
2.5.1 Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
3 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE BY PLAYER
3.1 Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Players
3.1.1 Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2018-2023)
3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2018-2023)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) BY REGIONS
4.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (2018-2023)
4.2 Americas Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
4.3 APAC Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
4.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
4.5 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023)
5.2 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
5.3 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023)
6.2 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
6.3 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Preimplantation Genetic Diagnostics (PGD) by Country (2018-2023)
7.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) by Region (2018-2023)
8.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
8.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET FORECAST
10.1 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Regions (2024-2029)
10.1.1 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Regions (2024-2029)
10.1.2 Americas Preimplantation Genetic Diagnostics (PGD) Forecast
10.1.3 APAC Preimplantation Genetic Diagnostics (PGD) Forecast
10.1.4 Europe Preimplantation Genetic Diagnostics (PGD) Forecast
10.1.5 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Forecast
10.2 Americas Preimplantation Genetic Diagnostics (PGD) Forecast by Country (2024-2029)
10.2.1 United States Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.2.2 Canada Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.2.3 Mexico Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.2.4 Brazil Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3 APAC Preimplantation Genetic Diagnostics (PGD) Forecast by Region (2024-2029)
10.3.1 China Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.2 Japan Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.3 Korea Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.4 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.5 India Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.6 Australia Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4 Europe Preimplantation Genetic Diagnostics (PGD) Forecast by Country (2024-2029)
10.4.1 Germany Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.2 France Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.3 UK Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.4 Italy Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.5 Russia Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Forecast by Region (2024-2029)
10.5.1 Egypt Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.2 South Africa Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.3 Israel Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.4 Turkey Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.5 GCC Countries Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.6 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Type (2024-2029)
10.7 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Information
11.1.2 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Illumina, Inc. Main Business Overview
11.1.5 Illumina, Inc. Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Information
11.3.2 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Agilent Technologies, Inc. Main Business Overview
11.3.5 Agilent Technologies, Inc. Latest Developments
11.4 Perkinelmer, Inc.
11.4.1 Perkinelmer, Inc. Company Information
11.4.2 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Perkinelmer, Inc. Main Business Overview
11.4.5 Perkinelmer, Inc. Latest Developments
11.5 Cooper Surgical
11.5.1 Cooper Surgical Company Information
11.5.2 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Offered
11.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cooper Surgical Main Business Overview
11.5.5 Cooper Surgical Latest Developments
11.6 ABBott Laboratories
11.6.1 ABBott Laboratories Company Information
11.6.2 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Offered
11.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 ABBott Laboratories Main Business Overview
11.6.5 ABBott Laboratories Latest Developments
11.7 Natera, Inc.
11.7.1 Natera, Inc. Company Information
11.7.2 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Natera, Inc. Main Business Overview
11.7.5 Natera, Inc. Latest Developments
11.8 Rubicon Genomics
11.8.1 Rubicon Genomics Company Information
11.8.2 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
11.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Rubicon Genomics Main Business Overview
11.8.5 Rubicon Genomics Latest Developments
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Information
11.9.2 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Offered
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Oxford Gene Technology Main Business Overview
11.9.5 Oxford Gene Technology Latest Developments
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Information
11.10.2 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
11.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Yikon Genomics Main Business Overview
11.10.5 Yikon Genomics Latest Developments
11.11 Scigene
11.11.1 Scigene Company Information
11.11.2 Scigene Preimplantation Genetic Diagnostics (PGD) Product Offered
11.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Scigene Main Business Overview
11.11.5 Scigene Latest Developments
11.12 Beijing Genomics Institute (BGI)
11.12.1 Beijing Genomics Institute (BGI) Company Information
11.12.2 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Offered
11.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Beijing Genomics Institute (BGI) Main Business Overview
11.12.5 Beijing Genomics Institute (BGI) Latest Developments
11.13 Genea Limited
11.13.1 Genea Limited Company Information
11.13.2 Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Offered
11.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Genea Limited Main Business Overview
11.13.5 Genea Limited Latest Developments
11.14 Hamilton Thorne
11.14.1 Hamilton Thorne Company Information
11.14.2 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Offered
11.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Hamilton Thorne Main Business Overview
11.14.5 Hamilton Thorne Latest Developments
11.15 FUJIFILM Irvine Scientific
11.15.1 FUJIFILM Irvine Scientific Company Information
11.15.2 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Offered
11.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 FUJIFILM Irvine Scientific Main Business Overview
11.15.5 FUJIFILM Irvine Scientific Latest Developments
11.16 Nidacon International
11.16.1 Nidacon International Company Information
11.16.2 Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Offered
11.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Nidacon International Main Business Overview
11.16.5 Nidacon International Latest Developments
11.17 Vitrolife AB
11.17.1 Vitrolife AB Company Information
11.17.2 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Offered
11.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Vitrolife AB Main Business Overview
11.17.5 Vitrolife AB Latest Developments
11.18 Merck
11.18.1 Merck Company Information
11.18.2 Merck Preimplantation Genetic Diagnostics (PGD) Product Offered
11.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Merck Main Business Overview
11.18.5 Merck Latest Developments
11.19 INVO Bioscience
11.19.1 INVO Bioscience Company Information
11.19.2 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Offered
11.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 INVO Bioscience Main Business Overview
11.19.5 INVO Bioscience Latest Developments
11.20 IVFtech
11.20.1 IVFtech Company Information
11.20.2 IVFtech Preimplantation Genetic Diagnostics (PGD) Product Offered
11.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 IVFtech Main Business Overview
11.20.5 IVFtech Latest Developments
11.21 Gonagen Medikal
11.21.1 Gonagen Medikal Company Information
11.21.2 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Offered
11.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Gonagen Medikal Main Business Overview
11.21.5 Gonagen Medikal Latest Developments
11.22 Cook Medical
11.22.1 Cook Medical Company Information
11.22.2 Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Offered
11.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Cook Medical Main Business Overview
11.22.5 Cook Medical Latest Developments
11.23 CellCura
11.23.1 CellCura Company Information
11.23.2 CellCura Preimplantation Genetic Diagnostics (PGD) Product Offered
11.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 CellCura Main Business Overview
11.23.5 CellCura Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2029
2.1.2 Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Preimplantation Genetic Diagnostics (PGD) Segment by Type
2.2.1 Preimplantation Genetic Screening
2.2.2 Preimplantation Genetic Diagnosis
2.3 Preimplantation Genetic Diagnostics (PGD) Market Size by Type
2.3.1 Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
2.4 Preimplantation Genetic Diagnostics (PGD) Segment by Application
2.4.1 Fertility Clinics
2.4.2 Academic Medical Centers
2.4.3 Others
2.5 Preimplantation Genetic Diagnostics (PGD) Market Size by Application
2.5.1 Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
3 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE BY PLAYER
3.1 Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Players
3.1.1 Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2018-2023)
3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2018-2023)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) BY REGIONS
4.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (2018-2023)
4.2 Americas Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
4.3 APAC Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
4.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
4.5 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023)
5.2 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
5.3 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023)
6.2 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
6.3 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Preimplantation Genetic Diagnostics (PGD) by Country (2018-2023)
7.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) by Region (2018-2023)
8.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023)
8.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET FORECAST
10.1 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Regions (2024-2029)
10.1.1 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Regions (2024-2029)
10.1.2 Americas Preimplantation Genetic Diagnostics (PGD) Forecast
10.1.3 APAC Preimplantation Genetic Diagnostics (PGD) Forecast
10.1.4 Europe Preimplantation Genetic Diagnostics (PGD) Forecast
10.1.5 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Forecast
10.2 Americas Preimplantation Genetic Diagnostics (PGD) Forecast by Country (2024-2029)
10.2.1 United States Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.2.2 Canada Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.2.3 Mexico Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.2.4 Brazil Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3 APAC Preimplantation Genetic Diagnostics (PGD) Forecast by Region (2024-2029)
10.3.1 China Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.2 Japan Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.3 Korea Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.4 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.5 India Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.3.6 Australia Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4 Europe Preimplantation Genetic Diagnostics (PGD) Forecast by Country (2024-2029)
10.4.1 Germany Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.2 France Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.3 UK Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.4 Italy Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.4.5 Russia Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Forecast by Region (2024-2029)
10.5.1 Egypt Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.2 South Africa Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.3 Israel Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.4 Turkey Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.5.5 GCC Countries Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.6 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Type (2024-2029)
10.7 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Information
11.1.2 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Illumina, Inc. Main Business Overview
11.1.5 Illumina, Inc. Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Information
11.3.2 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Agilent Technologies, Inc. Main Business Overview
11.3.5 Agilent Technologies, Inc. Latest Developments
11.4 Perkinelmer, Inc.
11.4.1 Perkinelmer, Inc. Company Information
11.4.2 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Perkinelmer, Inc. Main Business Overview
11.4.5 Perkinelmer, Inc. Latest Developments
11.5 Cooper Surgical
11.5.1 Cooper Surgical Company Information
11.5.2 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Offered
11.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cooper Surgical Main Business Overview
11.5.5 Cooper Surgical Latest Developments
11.6 ABBott Laboratories
11.6.1 ABBott Laboratories Company Information
11.6.2 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Offered
11.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 ABBott Laboratories Main Business Overview
11.6.5 ABBott Laboratories Latest Developments
11.7 Natera, Inc.
11.7.1 Natera, Inc. Company Information
11.7.2 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
11.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Natera, Inc. Main Business Overview
11.7.5 Natera, Inc. Latest Developments
11.8 Rubicon Genomics
11.8.1 Rubicon Genomics Company Information
11.8.2 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
11.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Rubicon Genomics Main Business Overview
11.8.5 Rubicon Genomics Latest Developments
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Information
11.9.2 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Offered
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Oxford Gene Technology Main Business Overview
11.9.5 Oxford Gene Technology Latest Developments
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Information
11.10.2 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
11.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Yikon Genomics Main Business Overview
11.10.5 Yikon Genomics Latest Developments
11.11 Scigene
11.11.1 Scigene Company Information
11.11.2 Scigene Preimplantation Genetic Diagnostics (PGD) Product Offered
11.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Scigene Main Business Overview
11.11.5 Scigene Latest Developments
11.12 Beijing Genomics Institute (BGI)
11.12.1 Beijing Genomics Institute (BGI) Company Information
11.12.2 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Offered
11.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Beijing Genomics Institute (BGI) Main Business Overview
11.12.5 Beijing Genomics Institute (BGI) Latest Developments
11.13 Genea Limited
11.13.1 Genea Limited Company Information
11.13.2 Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Offered
11.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Genea Limited Main Business Overview
11.13.5 Genea Limited Latest Developments
11.14 Hamilton Thorne
11.14.1 Hamilton Thorne Company Information
11.14.2 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Offered
11.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Hamilton Thorne Main Business Overview
11.14.5 Hamilton Thorne Latest Developments
11.15 FUJIFILM Irvine Scientific
11.15.1 FUJIFILM Irvine Scientific Company Information
11.15.2 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Offered
11.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 FUJIFILM Irvine Scientific Main Business Overview
11.15.5 FUJIFILM Irvine Scientific Latest Developments
11.16 Nidacon International
11.16.1 Nidacon International Company Information
11.16.2 Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Offered
11.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Nidacon International Main Business Overview
11.16.5 Nidacon International Latest Developments
11.17 Vitrolife AB
11.17.1 Vitrolife AB Company Information
11.17.2 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Offered
11.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Vitrolife AB Main Business Overview
11.17.5 Vitrolife AB Latest Developments
11.18 Merck
11.18.1 Merck Company Information
11.18.2 Merck Preimplantation Genetic Diagnostics (PGD) Product Offered
11.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Merck Main Business Overview
11.18.5 Merck Latest Developments
11.19 INVO Bioscience
11.19.1 INVO Bioscience Company Information
11.19.2 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Offered
11.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 INVO Bioscience Main Business Overview
11.19.5 INVO Bioscience Latest Developments
11.20 IVFtech
11.20.1 IVFtech Company Information
11.20.2 IVFtech Preimplantation Genetic Diagnostics (PGD) Product Offered
11.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 IVFtech Main Business Overview
11.20.5 IVFtech Latest Developments
11.21 Gonagen Medikal
11.21.1 Gonagen Medikal Company Information
11.21.2 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Offered
11.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Gonagen Medikal Main Business Overview
11.21.5 Gonagen Medikal Latest Developments
11.22 Cook Medical
11.22.1 Cook Medical Company Information
11.22.2 Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Offered
11.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Cook Medical Main Business Overview
11.22.5 Cook Medical Latest Developments
11.23 CellCura
11.23.1 CellCura Company Information
11.23.2 CellCura Preimplantation Genetic Diagnostics (PGD) Product Offered
11.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 CellCura Main Business Overview
11.23.5 CellCura Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Preimplantation Genetic Screening
Table 3. Major Players of Preimplantation Genetic Diagnosis
Table 4. Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 7. Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 10. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Player (2018-2023)
Table 12. Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Products Offered
Table 13. Preimplantation Genetic Diagnostics (PGD) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions (2018-2023)
Table 18. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Country (2018-2023)
Table 22. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 24. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 26. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region (2018-2023)
Table 28. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 30. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 32. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Country (2018-2023)
Table 34. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 36. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Preimplantation Genetic Diagnostics (PGD)
Table 45. Key Market Challenges & Risks of Preimplantation Genetic Diagnostics (PGD)
Table 46. Key Industry Trends of Preimplantation Genetic Diagnostics (PGD)
Table 47. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Illumina, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 52. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 53. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Illumina, Inc. Main Business
Table 55. Illumina, Inc. Latest Developments
Table 56. Thermo Fisher Scientific Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 58. Thermo Fisher Scientific Inc. Main Business
Table 59. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Thermo Fisher Scientific Inc. Latest Developments
Table 61. Agilent Technologies, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 62. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 63. Agilent Technologies, Inc. Main Business
Table 64. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Agilent Technologies, Inc. Latest Developments
Table 66. Perkinelmer, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 67. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 68. Perkinelmer, Inc. Main Business
Table 69. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Perkinelmer, Inc. Latest Developments
Table 71. Cooper Surgical Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 72. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 73. Cooper Surgical Main Business
Table 74. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Cooper Surgical Latest Developments
Table 76. ABBott Laboratories Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 77. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 78. ABBott Laboratories Main Business
Table 79. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. ABBott Laboratories Latest Developments
Table 81. Natera, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 82. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 83. Natera, Inc. Main Business
Table 84. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Natera, Inc. Latest Developments
Table 86. Rubicon Genomics Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 87. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 88. Rubicon Genomics Main Business
Table 89. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Rubicon Genomics Latest Developments
Table 91. Oxford Gene Technology Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 92. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 93. Oxford Gene Technology Main Business
Table 94. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Oxford Gene Technology Latest Developments
Table 96. Yikon Genomics Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 97. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 98. Yikon Genomics Main Business
Table 99. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Yikon Genomics Latest Developments
Table 101. Scigene Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 102. Scigene Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 103. Scigene Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Scigene Main Business
Table 105. Scigene Latest Developments
Table 106. Beijing Genomics Institute (BGI) Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 107. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 108. Beijing Genomics Institute (BGI) Main Business
Table 109. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Beijing Genomics Institute (BGI) Latest Developments
Table 111. Genea Limited Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 112. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 113. Genea Limited Main Business
Table 114. Genea Limited Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Genea Limited Latest Developments
Table 116. Hamilton Thorne Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 117. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 118. Hamilton Thorne Main Business
Table 119. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Hamilton Thorne Latest Developments
Table 121. FUJIFILM Irvine Scientific Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 122. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 123. FUJIFILM Irvine Scientific Main Business
Table 124. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. FUJIFILM Irvine Scientific Latest Developments
Table 126. Nidacon International Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 127. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 128. Nidacon International Main Business
Table 129. Nidacon International Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Nidacon International Latest Developments
Table 131. Vitrolife AB Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 132. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 133. Vitrolife AB Main Business
Table 134. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Vitrolife AB Latest Developments
Table 136. Merck Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 137. Merck Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 138. Merck Main Business
Table 139. Merck Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Merck Latest Developments
Table 141. INVO Bioscience Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 142. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 143. INVO Bioscience Main Business
Table 144. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. INVO Bioscience Latest Developments
Table 146. IVFtech Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 147. IVFtech Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 148. IVFtech Main Business
Table 149. IVFtech Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. IVFtech Latest Developments
Table 151. Gonagen Medikal Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 152. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 153. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Gonagen Medikal Main Business
Table 155. Gonagen Medikal Latest Developments
Table 156. Cook Medical Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 157. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 158. Cook Medical Main Business
Table 159. Cook Medical Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Cook Medical Latest Developments
Table 161. CellCura Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 162. CellCura Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 163. CellCura Main Business
Table 164. CellCura Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. CellCura Latest Developments
Table 1. Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Preimplantation Genetic Screening
Table 3. Major Players of Preimplantation Genetic Diagnosis
Table 4. Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 7. Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 10. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Player (2018-2023)
Table 12. Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Products Offered
Table 13. Preimplantation Genetic Diagnostics (PGD) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions (2018-2023)
Table 18. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Country (2018-2023)
Table 22. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 24. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 26. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region (2018-2023)
Table 28. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 30. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 32. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Country (2018-2023)
Table 34. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 36. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Preimplantation Genetic Diagnostics (PGD)
Table 45. Key Market Challenges & Risks of Preimplantation Genetic Diagnostics (PGD)
Table 46. Key Industry Trends of Preimplantation Genetic Diagnostics (PGD)
Table 47. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Illumina, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 52. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 53. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Illumina, Inc. Main Business
Table 55. Illumina, Inc. Latest Developments
Table 56. Thermo Fisher Scientific Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 58. Thermo Fisher Scientific Inc. Main Business
Table 59. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Thermo Fisher Scientific Inc. Latest Developments
Table 61. Agilent Technologies, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 62. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 63. Agilent Technologies, Inc. Main Business
Table 64. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Agilent Technologies, Inc. Latest Developments
Table 66. Perkinelmer, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 67. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 68. Perkinelmer, Inc. Main Business
Table 69. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Perkinelmer, Inc. Latest Developments
Table 71. Cooper Surgical Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 72. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 73. Cooper Surgical Main Business
Table 74. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Cooper Surgical Latest Developments
Table 76. ABBott Laboratories Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 77. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 78. ABBott Laboratories Main Business
Table 79. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. ABBott Laboratories Latest Developments
Table 81. Natera, Inc. Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 82. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 83. Natera, Inc. Main Business
Table 84. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Natera, Inc. Latest Developments
Table 86. Rubicon Genomics Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 87. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 88. Rubicon Genomics Main Business
Table 89. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Rubicon Genomics Latest Developments
Table 91. Oxford Gene Technology Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 92. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 93. Oxford Gene Technology Main Business
Table 94. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Oxford Gene Technology Latest Developments
Table 96. Yikon Genomics Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 97. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 98. Yikon Genomics Main Business
Table 99. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Yikon Genomics Latest Developments
Table 101. Scigene Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 102. Scigene Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 103. Scigene Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Scigene Main Business
Table 105. Scigene Latest Developments
Table 106. Beijing Genomics Institute (BGI) Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 107. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 108. Beijing Genomics Institute (BGI) Main Business
Table 109. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Beijing Genomics Institute (BGI) Latest Developments
Table 111. Genea Limited Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 112. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 113. Genea Limited Main Business
Table 114. Genea Limited Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Genea Limited Latest Developments
Table 116. Hamilton Thorne Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 117. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 118. Hamilton Thorne Main Business
Table 119. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Hamilton Thorne Latest Developments
Table 121. FUJIFILM Irvine Scientific Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 122. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 123. FUJIFILM Irvine Scientific Main Business
Table 124. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. FUJIFILM Irvine Scientific Latest Developments
Table 126. Nidacon International Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 127. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 128. Nidacon International Main Business
Table 129. Nidacon International Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Nidacon International Latest Developments
Table 131. Vitrolife AB Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 132. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 133. Vitrolife AB Main Business
Table 134. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Vitrolife AB Latest Developments
Table 136. Merck Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 137. Merck Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 138. Merck Main Business
Table 139. Merck Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Merck Latest Developments
Table 141. INVO Bioscience Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 142. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 143. INVO Bioscience Main Business
Table 144. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. INVO Bioscience Latest Developments
Table 146. IVFtech Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 147. IVFtech Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 148. IVFtech Main Business
Table 149. IVFtech Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. IVFtech Latest Developments
Table 151. Gonagen Medikal Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 152. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 153. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Gonagen Medikal Main Business
Table 155. Gonagen Medikal Latest Developments
Table 156. Cook Medical Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 157. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 158. Cook Medical Main Business
Table 159. Cook Medical Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Cook Medical Latest Developments
Table 161. CellCura Details, Company Type, Preimplantation Genetic Diagnostics (PGD) Area Served and Its Competitors
Table 162. CellCura Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 163. CellCura Main Business
Table 164. CellCura Preimplantation Genetic Diagnostics (PGD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. CellCura Latest Developments
LIST OF FIGURES
Figure 1. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Preimplantation Genetic Diagnostics (PGD) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country/Region (2022)
Figure 8. Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2022
Figure 10. Preimplantation Genetic Diagnostics (PGD) in Fertility Clinics
Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market: Fertility Clinics (2018-2023) & ($ Millions)
Figure 12. Preimplantation Genetic Diagnostics (PGD) in Academic Medical Centers
Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market: Academic Medical Centers (2018-2023) & ($ Millions)
Figure 14. Preimplantation Genetic Diagnostics (PGD) in Others
Figure 15. Global Preimplantation Genetic Diagnostics (PGD) Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2022
Figure 17. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Player in 2022
Figure 18. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 20. APAC Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 21. Europe Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 23. Americas Preimplantation Genetic Diagnostics (PGD) Value Market Share by Country in 2022
Figure 24. United States Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region in 2022
Figure 29. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2022
Figure 30. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2022
Figure 31. China Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Country in 2022
Figure 38. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Figure 39. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Figure 40. Germany Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 54. APAC Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 55. Europe Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 57. United States Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 58. Canada Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 61. China Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 62. Japan Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 63. Korea Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 65. India Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 66. Australia Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 67. Germany Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 68. France Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 69. UK Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 70. Italy Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 71. Russia Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 72. Spain Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 75. Israel Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 78. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Preimplantation Genetic Diagnostics (PGD) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country/Region (2022)
Figure 8. Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2022
Figure 10. Preimplantation Genetic Diagnostics (PGD) in Fertility Clinics
Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market: Fertility Clinics (2018-2023) & ($ Millions)
Figure 12. Preimplantation Genetic Diagnostics (PGD) in Academic Medical Centers
Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market: Academic Medical Centers (2018-2023) & ($ Millions)
Figure 14. Preimplantation Genetic Diagnostics (PGD) in Others
Figure 15. Global Preimplantation Genetic Diagnostics (PGD) Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2022
Figure 17. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Player in 2022
Figure 18. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 20. APAC Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 21. Europe Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2018-2023 ($ Millions)
Figure 23. Americas Preimplantation Genetic Diagnostics (PGD) Value Market Share by Country in 2022
Figure 24. United States Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region in 2022
Figure 29. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2022
Figure 30. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2022
Figure 31. China Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Country in 2022
Figure 38. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Figure 39. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Figure 40. Germany Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 54. APAC Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 55. Europe Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 57. United States Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 58. Canada Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 61. China Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 62. Japan Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 63. Korea Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 65. India Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 66. Australia Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 67. Germany Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 68. France Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 69. UK Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 70. Italy Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 71. Russia Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 72. Spain Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 75. Israel Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Preimplantation Genetic Diagnostics (PGD) Market Size 2024-2029 ($ Millions)
Figure 78. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Application (2024-2029)
